3QBD was founded in April 2000 by two highly skilled professionals, Dr. Avraham Lorber and Dr. Zeev Karpas, both well known analytical chemists, each with over 30 years experience in the area of biotechnology.
3QBD's vision has always been to provide the field of Women's...Read more

3QBD was founded in April 2000 by two highly skilled professionals, Dr. Avraham Lorber and Dr. Zeev Karpas, both well known analytical chemists, each with over 30 years experience in the area of biotechnology.
3QBD's vision has always been to provide the field of Women's Healthcare with a new diagnostic tool that would improve the health and wellbeing of women throughout the world. Today, with the first 3QBD Solution, women can receive better healthcare as their gynecologists, obstetricians or healthcare practitioners are able to diagnose vaginal infections more accurately, effectively and efficiently, and so prescribe the correct treatment for their conditionwithout delay.
Future developments for 3QBD include expanding research into other medical fields, to detect additional infections and diseases, particularly in oncology.

Sight Diagnostics is a medical device company developing a novel platform for diagnosing blood diseases using computer vision technology. Our detection technology combines cutting-edge applications from the fields of computer hardware, software and biology to deliver the...Read more

Sight Diagnostics is a medical device company developing a novel platform for diagnosing blood diseases using computer vision technology. Our detection technology combines cutting-edge applications from the fields of computer hardware, software and biology to deliver the fastest and most accurate diagnostic performance. Our flagship product, the Parasight plafrom, identifies, enumerates and speciates malaria more accurately than all other currently used diagnostics. In the future, our platform technology will be used to identify additional anomalies in blood and body fluids.

For more than 25 years Savyon Diagnostics has gained its reputation as a company specializing in development, manufacturing and marketing of in vitro diagnostics kits.
Our core business is manufacturing high-quality test systems for the diagnosis of Infectious Diseases...Read more

For more than 25 years Savyon Diagnostics has gained its reputation as a company specializing in development, manufacturing and marketing of in vitro diagnostics kits.
Our core business is manufacturing high-quality test systems for the diagnosis of Infectious Diseases and for Genetic Screening through a worldwide distribution network. We are constantly progressing and improving as we always seek to comply with our customers’ needs through innovative development yielding top-notch quality products. A recent accomplishment is the implementation of the NanoCHIP platform and its application for high throughput multi-analyte molecular testing.
Our tests are based upon various techniques: ELISA, MIF, IPA, Immunochromatographic rapid kits, DNA/RNA Micro Arrays and more.
Savyon’s strength is built upon scientific stringency, unmatched customer support, as well as maintaining close relationships with international key opinion leaders and academic institutions, thus establishing its position as an innovative key player in diagnosis of infectious diseases.

CNOGA medical is a leading global company for Remote monitoring. CNOGA is a privately held international company, founded in 2004, with headquarters in Israel and subsidiaries in China and Brazil. CNOGA researches and develops innovative technologies in the field of...Read more

CNOGA medical is a leading global company for Remote monitoring. CNOGA is a privately held international company, founded in 2004, with headquarters in Israel and subsidiaries in China and Brazil. CNOGA researches and develops innovative technologies in the field of non-invasive medical devices that integrated into our data management platform to provide a complete solution for the patients and the physicians.
By simply placing a finger into one compact medical device for one minute, TensorTip MTX can measure 15 bio-parameters such as Hemodynamic, Hematology and Blood gasses without the need to draw blood. With the use of dedicated Singular Apps and eHealth management cloud system the data can be safely managed, analyzed and shared for remote monitoring.
CNOGA's devices are approved by CE, CFDA, Anvisa and having a U.S FDA approval for Blood pressure & Pulse.

DermaCompare is a revolutionary skin cancer screening platform that enables physicians to identify and monitor changes in their patients’ skin characteristics. DermaCompare was developed by Emerald Medical Applications, a digital health startup. Emerald specializes in...Read more

DermaCompare is a revolutionary skin cancer screening platform that enables physicians to identify and monitor changes in their patients’ skin characteristics. DermaCompare was developed by Emerald Medical Applications, a digital health startup. Emerald specializes in image processing software infrastructure solutions for an extensive range of applications for diverse medical unmet needs. Emerald’s technology utilizes the knowledge of military image processing and big data analytics to improve the analysis of medical images for the benefit of patients and the medical community alike.
DermaCompare is the first application of Emerald’s technology and innovation and it is set to revolutionize the world of dermatology and aid the early detection of skin cancer.

ATLASense is an early-stage startup company, developing a unique medical platform to continuously and comprehensively remote surveillance of people's health.

This platform includes a special developed credit card size device: the PolyMonitor.
This...Read more

ATLASense is an early-stage startup company, developing a unique medical platform to continuously and comprehensively remote surveillance of people's health.

This platform includes a special developed credit card size device: the PolyMonitor.
This PolyMonitor is attached to the chest by a disposable patch or as part of a smart shirt.
It is reusable and multi-functional and aimed to replace an array of bulky and expensive monitors in less than 10% of the cost of use. It is fully remotely controlled by doctors that can configure its functionality according to each patient's condition.
It can early detect deterioration and life-threatening events and alert to early treatment and prevention.

Micromedic Technologies Ltd. is a public company traded on the Tel Aviv Stock Exchange (MCTC), focusing on the development and commercialization of cancer diagnostics products.
Micromedic forms a cluster that manages the development of a variety of products across the...Read more

Micromedic Technologies Ltd. is a public company traded on the Tel Aviv Stock Exchange (MCTC), focusing on the development and commercialization of cancer diagnostics products.
Micromedic forms a cluster that manages the development of a variety of products across the cancer diagnostic value chain. From screening and risk identification, through diagnostics, personalized medicine, and monitoring disease recurrence,
Micromedic identifies projects that fill unmet needs in various cancer related indications, and turns them into viable marketable products.
Micromedic operates through strategic collaborations and in-licensing from leading scientific institutes worldwide as well as in-house based research.
As of December 2011 the company's larger share holder, BioLight Life Sciences Investments (TASE: BOLT, OTCQX: BLGTY), realizes its clusters approach by forming the “Cancer Diagnostic Cluster”.